Literature DB >> 19444143

Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?

Laima Siddiqi1, Jaap A Joles, Guido Grassi, Peter J Blankestijn.   

Abstract

In chronic kidney disease simultaneous activation of the renin-angiotensin and sympathetic systems occurs. Kidney ischemia seems to play a key role in the pathogenesis. This review firstly summarizes experimental and clinical evidence in chronic kidney disease supporting this idea and addresses the possibility that this mechanism is also relevant in some other disease conditions.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19444143     DOI： 10.1097/HJH.0b013e32832b521b

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


  20 in total

1.  Hypertension: Renal denervation in chronic kidney disease.

Authors:  Peter J Blankestijn; Jaap A Joles
Journal:  Nat Rev Nephrol       Date:  2012-07-03       Impact factor: 28.314

Review 2.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

3.  Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.

Authors:  Guido Grassi; Gino Seravalle; Lorenzo Ghiadoni; Giovanni Tripepi; Rosa Maria Bruno; Giuseppe Mancia; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

Review 4.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

Review 5.  Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation?

Authors:  Lisette E G Hubens; Willemien L Verloop; Jaap A Joles; Peter J Blankestijn; Michiel Voskuil
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

6.  Renal denervation: a new treatment option in resistant arterial hypertension.

Authors:  W L Verloop; M Voskuil; P A Doevendans
Journal:  Neth Heart J       Date:  2013-02       Impact factor: 2.380

Review 7.  Nondrug interventions for treatment of hypertension.

Authors:  Kevin J Woolf; John D Bisognano
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-08-25       Impact factor: 3.738

Review 8.  Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease.

Authors:  Gino Seravalle; Fosca Quarti-Trevano; Jennifer Vanoli; Chiara Lovati; Guido Grassi
Journal:  Clin Auton Res       Date:  2021-02-19       Impact factor: 4.435

9.  Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience.

Authors:  M Voskuil; W L Verloop; P J Blankestijn; P Agostoni; P R Stella; P A Doevendans
Journal:  Neth Heart J       Date:  2011-08       Impact factor: 2.380

10.  Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease.

Authors:  Laima Siddiqi; Hans Hoogduin; Freddy Visser; Tim Leiner; Willem P Mali; Peter J Blankestijn
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-20       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.